Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322.
Cold Spring Harb Perspect Biol. 2019 Jan 2;11(1):a028464. doi: 10.1101/cshperspect.a028464.
The common γ-chain cytokines, interleukin (IL)-2, IL-7, and IL-15, regulate critical aspects of antiviral CD8 T-cell responses. During acute infections, IL-2 controls expansion and differentiation of antiviral CD8 T cells, whereas IL-7 and IL-15 are key cytokines to maintain memory CD8 T cells long term in an antigen-independent manner. On the other hand, during chronic infections, in which T-cell exhaustion is established, precise roles of these cytokines in regulation of antiviral CD8 T-cell responses are not well defined. Nonetheless, administration of IL-2, IL-7, or IL-15 can increase function of exhausted CD8 T cells, and thus can be an attractive therapeutic approach. A new subset of stem-cell-like CD8 T cells, which provides a proliferative burst after programmed cell death (PD)-1 therapy, has been recently described during chronic viral infection. Further understanding of cytokine-mediated regulation of this CD8 T-cell subset will improve cytokine therapies to treat chronic infections and cancer in combination with immune checkpoint inhibitors.
共同γ链细胞因子白细胞介素(IL)-2、IL-7 和 IL-15 调节抗病毒 CD8 T 细胞反应的关键方面。在急性感染期间,IL-2 控制抗病毒 CD8 T 细胞的扩增和分化,而 IL-7 和 IL-15 是在抗原非依赖性方式中长期维持记忆 CD8 T 细胞的关键细胞因子。另一方面,在建立 T 细胞耗竭的慢性感染中,这些细胞因子在调节抗病毒 CD8 T 细胞反应中的精确作用尚未明确。尽管如此,IL-2、IL-7 或 IL-15 的给药可以增加耗竭的 CD8 T 细胞的功能,因此可以成为一种有吸引力的治疗方法。在慢性病毒感染期间,最近描述了一个新的干细胞样 CD8 T 细胞亚群,该亚群在程序性细胞死亡(PD)-1 治疗后提供增殖爆发。进一步了解细胞因子介导的这种 CD8 T 细胞亚群的调节将改善细胞因子疗法,以联合免疫检查点抑制剂治疗慢性感染和癌症。